Icecure Medical is trading 11.11% higher in pre-market at $1.20, compared with its October 19 close of $1.08; the catalyst remains unclear. - Available search results showed no new company announcement or clearly reported catalyst for October 20. - The latest company-specific news found was October 13 clinical data and physician engagement at EUSOBI; it predates the move and does not establish its cause. - Broad market signals were mixed, offering no clear market-wide explanation.